PDS Biotechnology Corp is a clinical-stage immunotherapy company developing targeted cancer and infectious disease immunotherapies. Its pipeline is based on the Versamune T cell activator platform, the IL-12 fused antibody drug conjugate PDS01ADC, and the Infectimune T cell activator. Lead product PDS0101 is in Phase 3 trials for HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma, with additional programs in cervical cancer and colorectal cancer.
expected 2026-12-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001140361-26-012030 | EDGAR | 101K words |
| 2025-03-27 | 2024-12-31 | 0001140361-25-010717 | EDGAR | 99K words |
| 2024-03-28 | 2023-12-31 | 0001140361-24-016265 | EDGAR | 96K words |
| 2023-03-28 | 2022-12-31 | 0001140361-23-014279 | EDGAR | 91K words |
| 2022-03-31 | 2021-12-31 | 0001140361-22-012244 | EDGAR | — |
| 2021-03-18 | 2020-12-31 | 0001140361-21-009142 | EDGAR | — |
| 2020-03-27 | 2019-12-31 | 0001140361-20-007252 | EDGAR | — |
| 2019-02-21 | 2018-12-31 | 0001140361-19-003636 | EDGAR | — |
| 2018-03-01 | 2017-12-31 | 0001140361-18-011218 | EDGAR | — |
| 2017-03-02 | 2016-12-31 | 0001140361-17-010287 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001140361-26-032824 | EDGAR | 38K words |
| 2025-11-13 | 2025-09-30 | 0001140361-25-041976 | EDGAR | 26K words |
| 2025-08-13 | 2025-06-30 | 0001140361-25-030825 | EDGAR | 26K words |
| 2025-05-14 | 2025-03-31 | 0001140361-25-018967 | EDGAR | 22K words |
| 2024-11-14 | 2024-09-30 | 0001140361-24-046891 | EDGAR | 25K words |
| 2024-08-13 | 2024-06-30 | 0001140361-24-037067 | EDGAR | 25K words |
| 2024-05-15 | 2024-03-31 | 0001140361-24-026295 | EDGAR | 23K words |
| 2023-11-14 | 2023-09-30 | 0001140361-23-053242 | EDGAR | 25K words |
| 2023-08-14 | 2023-06-30 | 0001140361-23-039544 | EDGAR | 23K words |
| 2023-05-15 | 2023-03-31 | 0001140361-23-024692 | EDGAR | 21K words |
| 2022-11-14 | 2022-09-30 | 0001140361-22-041370 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001140361-22-028567 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-22 | 0001140361-26-037298 | EDGAR | 1K words |
| 2026-09-21 | 0001140361-26-037234 | EDGAR | 3K words |
| 2026-09-14 | 0001140361-26-036489 | EDGAR | 2K words |
| 2026-09-08 | 0001140361-26-035853 | EDGAR | 2K words |
| 2026-09-04 | 0001140361-26-035809 | EDGAR | 2K words |
| 2026-08-25 | 0001140361-26-034320 | EDGAR | 1K words |
| 2026-08-19 | 0001140361-26-033749 | EDGAR | 1K words |
| 2026-08-14 | 0001140361-26-032947 | EDGAR | 1K words |
| 2026-08-13 | 0001140361-26-032650 | EDGAR | 2K words |
| 2026-08-11 | 0001140361-26-032142 | EDGAR | 2K words |
349 total filings indexed. 317 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001472091 |
| Ticker | PDSB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.pdsbiotech.com |
| Listed | 2015-10-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PDSB (~200 tokens, structured JSON with cryptographic provenance)